1.7900
+0.0200
+(1.13%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-16,474.0000
-16,474.0000
-28,151.0000
-47,242.0000
-43,745.0000
Investing Cash Flow
-100.0000
-100.0000
18,247.0000
-20,413.0000
-52.0000
Financing Cash Flow
4.0000
4.0000
3,431.0000
1.0000
117,835.0000
End Cash Position
17,750.0000
17,750.0000
34,396.0000
41,625.0000
109,537.0000
Income Tax Paid Supplemental Data
36.0000
36.0000
367.0000
22.0000
--
Interest Paid Supplemental Data
--
--
17.0000
91.0000
85.0000
Capital Expenditure
-100.0000
-100.0000
-34.0000
-2,844.0000
-52.0000
Issuance of Capital Stock
--
--
--
--
112,577.0000
Issuance of Debt
--
--
--
--
670.0000
Repayment of Debt
--
--
-1,569.0000
--
-64.0000
Free Cash Flow
-16,574.0000
-16,574.0000
-28,185.0000
-50,086.0000
-43,797.0000
12/31/2020 - 3/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
2.2100
-1.78%
CNTB Connect Biopharma Holdings Limited
0.9720
-3.76%
ELDN Eledon Pharmaceuticals, Inc.
4.5200
-5.44%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
ADAG Adagene Inc.
1.9000
+2.70%
ACTU Actuate Therapeutics, Inc. Common stock
9.03
+2.27%
XTLB XTL Biopharmaceuticals Ltd.
1.5899
-1.25%
CALC CalciMedica, Inc.
2.5600
+0.79%
DYAI Dyadic International, Inc.
1.4900
0.00%
GTBP GT Biopharma, Inc.
2.2300
+8.25%